Home › Funds › EQUITEC PROPRIETARY MARKETS, LLC › PMCB
EQUITEC PROPRIETARY MARKETS, LLC position in PMCB
PHARMACYTE BIOTECH INC · Health Care
EQUITEC PROPRIETARY MARKETS, LLC reported holding 22,227 shares of PMCB (PHARMACYTE BIOTECH INC) in its Q3 2026 13F filing — a position valued at US$9K, representing 0.01% of its reported portfolio and ranking #35 among its reported holdings. EQUITEC PROPRIETARY MARKETS, LLC has disclosed PMCB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How EQUITEC PROPRIETARY MARKETS, LLC's PMCB position evolved
EQUITEC PROPRIETARY MARKETS, LLC first disclosed a stake in PMCB in Q3 2023 at 82,727 shares (US$174K). The position peaked in Q1 2024 at 82,727 shares, worth US$196K. Across 13 filings, EQUITEC PROPRIETARY MARKETS, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 22,227 shares valued at US$9K. Notable position changes include a 73% trim in Q4 2025 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 82.73K | $173.73K | New |
| Q4 2023 | 82.73K | $178.69K | Hold |
| Q1 2024 | 82.73K | $196.06K | Hold |
| Q2 2024 | 82.73K | $162.15K | Hold |
| Q3 2024 | 82.73K | $158.01K | Hold |
| Q4 2024 | 82.73K | $129.88K | Hold |
| Q1 2025 | 82.73K | $103.41K | Hold |
| Q2 2025 | 82.73K | $90.17K | Hold |
| Q3 2025 | 82.73K | $80.21K | Hold |
| Q4 2025 | 22.23K | $16.09K | Reduce |
| Q1 2026 | 22.23K | $14.79K | Hold |
| Q2 2026 | 22.23K | $17.11K | Hold |
| Q3 2026 | 22.23K | $9.13K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PMCB and 13F data
PMCB (PHARMACYTE BIOTECH INC) is a Health Care company. 21 other funds we track also report a position in PMCB. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on EQUITEC PROPRIETARY MARKETS, LLC
FAQ
How long has EQUITEC PROPRIETARY MARKETS, LLC held PMCB?
EQUITEC PROPRIETARY MARKETS, LLC has disclosed PMCB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is EQUITEC PROPRIETARY MARKETS, LLC's current position in PMCB?
As of Q3 2026, EQUITEC PROPRIETARY MARKETS, LLC holds 22.23K shares of PMCB (PHARMACYTE BIOTECH INC), valued at $9.13K, representing 0.01% of its reported portfolio and ranking #35.
Has EQUITEC PROPRIETARY MARKETS, LLC been buying or selling PMCB?
In the latest 13F filing (Q3 2026), EQUITEC PROPRIETARY MARKETS, LLC held unchanged its position in PMCB. The position peaked in Q1 2024 at 82.73K shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.